Novel L-nucleoside analogue, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia

Haematologica. 2021 Feb 1;106(2):574-579. doi: 10.3324/haematol.2019.226795.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytarabine
  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy
  • Nucleosides*

Substances

  • Nucleosides
  • Cytarabine

Grants and funding